Franklin Genomic Advancements ETF (HELX)
BATS: HELX · Real-Time Price · USD
38.83
-0.92 (-2.31%)
Jul 31, 2026, 4:00 PM EDT - Market closed
HELX Holdings Information
HELX is an equity ETF with a total of 70 individual holdings. The top holdings are Guardant Health stock at 8.97%, Natera at 7.16%, Krystal Biotech at 6.35%, Ligand Pharmaceuticals at 4.32%, and Adaptive Biotechnologies at 4.31%.
Total Holdings
70
Top 10 Percentage
47.48%
Asset Class
Equity
ETF Category
Health
Assets
29.13M
PE Ratio
33.05
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GH | Guardant Health, Inc. | 8.97% |
| 2 | NTRA | Natera, Inc. | 7.16% |
| 3 | KRYS | Krystal Biotech, Inc. | 6.35% |
| 4 | LGND | Ligand Pharmaceuticals Incorporated | 4.32% |
| 5 | ADPT | Adaptive Biotechnologies Corporation | 4.31% |
| 6 | BBIO | BridgeBio Pharma, Inc. | 4.03% |
| 7 | UTHR | United Therapeutics Corporation | 3.49% |
| 8 | LLY | Eli Lilly and Company | 3.06% |
| 9 | CTVA | Corteva, Inc. | 3.04% |
| 10 | VRTX | Vertex Pharmaceuticals Incorporated | 2.74% |
| 11 | KRX: 207940 | Samsung Biologics Co.,Ltd. | 2.64% |
| 12 | TVTX | Travere Therapeutics, Inc. | 2.60% |
| 13 | LON: AZN | AstraZeneca PLC | 2.53% |
| 14 | MEDP | Medpace Holdings, Inc. | 2.43% |
| 15 | TWST | Twist Bioscience Corporation | 2.43% |
| 16 | REGN | Regeneron Pharmaceuticals, Inc. | 2.06% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 2.03% |
| 18 | VCYT | Veracyte, Inc. | 1.79% |
| 19 | EBR: ARGX | argenx SE | 1.60% |
| 20 | TEM | Tempus AI, Inc. | 1.44% |
| 21 | BNTX | BioNTech SE | 1.42% |
| 22 | PTCT | PTC Therapeutics, Inc. | 1.37% |
| 23 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.34% |
| 24 | CRL | Charles River Laboratories International, Inc. | 1.34% |
| 25 | STOK | Stoke Therapeutics, Inc. | 1.23% |
As of Jul 29, 2026